Efficacy and safety of iguratimod in the treatment of rheumatic and autoimmune diseases: a meta-analysis and systematic review of 84 randomized controlled trials

Efficacy and safety of iguratimod in the treatment of rheumatic and autoimmune diseases: a meta-analysis and systematic review of 84 randomized controlled trials

Objective: To evaluate efficacy and safety of iguratimod (IGU) in the treatment of rheumatic and autoimmune diseases.Methods: Databases such as Pubmed, Embase, Sinomed were searched (as of July 2022) to collect randomized controlled trials (RCTs) of IGU in the treatment of rheumatic and autoimmune d...

Full description

Bibliographic Details
Main Authors:	Liuting Zeng, Qi He, Ying Deng, Yuwei Li, Junpeng Chen, Kailin Yang, Yanfang Luo, Anqi Ge, Xiaofei Zhu, Zhiyong Long, Lingyun Sun
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-12-01
Series:	Frontiers in Pharmacology
Subjects:	autoimmune disease iguratimod rheumatoid arthritis ankylosing spondylitis primary Sjögren’s syndrome autoimmune disease with interstitial pneumonia
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1189142/full

Similar Items

Research progress on the clinical application and mechanism of iguratimod in the treatment of autoimmune diseases and rheumatic diseases
by: Zhiyong Long, et al.
Published: (2023-09-01)

Efficacy and safety of Iguratimod in the treatment of Ankylosing Spondylitis: A systematic review and meta-analysis of randomized controlled trials
by: Zhiyong Long, et al.
Published: (2023-03-01)

Iguratimod suppresses Tfh cell differentiation in primary Sjögren’s syndrome patients through inhibiting Akt/mTOR/STAT3 signaling
by: Taibiao Lyu, et al.
Published: (2023-08-01)

Iguratimod efficacy in palindromic rheumatism treatment
by: Fangfang Yuan, et al.
Published: (2023-06-01)

Primary Biliary Cholangitis with Ankylosing Spondylitis
by: Young Mi Hong, et al.
Published: (2022-06-01)

Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trials
by: Liuting Zeng, et al.
Published: (2024-03-01)

Vitamin D and Autoimmune Rheumatic Diseases
by: Lambros Athanassiou, et al.
Published: (2023-04-01)

The Effect and Safety of Iguratimod Combined With Methotrexate on Rheumatoid Arthritis: A Systematic Review and Meta-Analysis Based on a Randomized Controlled Trial
by: Liuting Zeng, et al.
Published: (2022-01-01)

Efficacy, safety and immunogenicity of a trivalent inactivated split influenza vaccine in patients with rheumatic diseases
by: D. V. Bukhanova, et al.
Published: (2018-07-01)

Interstitial Lung Disease with Autoimmune Features Successfully Treated with Mycophenolate Mofetil: Case Report
by: Sabrina Khuder, et al.
Published: (2023-12-01)

Ras family signaling pathway in immunopathogenesis of inflammatory rheumatic diseases
by: Mina Sadeghi Shaker, et al.
Published: (2023-05-01)

The usual Interstitial pneumonia pattern in autoimmune rheumatic diseases
by: Fabrizio Luppi, et al.
Published: (2023-12-01)

Acute spinal cord infarction secondary to ankylosing spondylitis: a case report and literature review
by: Wenjuan Li, et al.
Published: (2023-09-01)

Iguratimod Ameliorates the Severity of Secondary Progressive Multiple Sclerosis in Model Mice by Directly Inhibiting IL-6 Production and Th17 Cell Migration via Mitigation of Glial Inflammation
by: Satoshi Nagata, et al.
Published: (2023-09-01)

Belimumab treatment in autoimmune hepatitis and primary biliary cholangitis – a case series
by: Mirjam Kolev, et al.
Published: (2023-01-01)

The Effects of Biologics on Hematologic Malignancy Development in Patients with Ankylosing Spondylitis, Psoriasis, or Psoriatic Arthritis: A National Cohort Study
by: Chia-Jung Tsai, et al.
Published: (2023-09-01)

Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration Is Essential
by: Marco Sebastiani, et al.
Published: (2020-12-01)

Iguratimod: Novel Molecular Insights and a New csDMARD for Rheumatoid Arthritis, from Japan to the World
by: Yuji Nozaki
Published: (2021-05-01)

Efficacy of iguratimod on mineral and bone disorders after kidney transplantation: a preliminary study
by: Li Sun, et al.
Published: (2023-12-01)

Efficacy and Safety of Rituximab in Autoimmune Disease—Associated Interstitial Lung Disease: A Prospective Cohort Study
by: Natalia Mena-Vázquez, et al.
Published: (2022-02-01)

The Spectrum of Interstitial Lung Disease Associated with Autoimmune Diseases: Data of a 3.6-Year Prospective Study from a Referral Center of Interstitial Lung Disease and Lung Transplantation <sup>†</sup>
by: Belén Atienza-Mateo, et al.
Published: (2020-05-01)

Ezetimibe ameliorates clinical symptoms in a mouse model of ankylosing spondylitis associated with suppression of Th17 differentiation
by: Jeonghyeon Moon, et al.
Published: (2022-08-01)

Molecular autoimmunity
by: Zouali, Moncef, 1952-
Published: (2005)

Interstitial pneumonia with autoimmune features: monocentric prospective study
by: Larisa A. Akulkina, et al.
Published: (2023-04-01)

The Autoimmune Rheumatic Disease Related Dry Eye and Its Association with Retinopathy
by: Huimin Shan, et al.
Published: (2023-04-01)

The Role of Nintedanib in the Treatment of Progressive Pulmonary Fibrosis of Autoimmune-Related Interstitial Lung Disease
by: Aulia Rahman Ardan, et al.
Published: (2023-11-01)

A single-center study of clinical features of pediatric Sjögren’s syndrome
by: Ling Hou, et al.
Published: (2023-10-01)

Current State of Knowledge on Primary Sjögren’s Syndrome, an Autoimmune Exocrinopathy
by: Dorian Parisis, et al.
Published: (2020-07-01)

Iguratimod as an alternative therapy for systemic sclerosis and prevention of the occurrence of ischemic digital ulcer
by: Qingran Yan, et al.
Published: (2023-05-01)

Low Vitamin D Levels Predict Mortality in Ankylosing Spondylitis Patients: A Nationwide Population-Based Cohort Study
by: Niv Ben-Shabat, et al.
Published: (2020-05-01)

Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center and Literature Review
by: Belén Atienza-Mateo, et al.
Published: (2020-09-01)

A prospective observational cohort study of the efficacy of tofacitinib plus iguratimod on rheumatoid arthritis with usual interstitial pneumonia
by: Shuhua Wang, et al.
Published: (2023-08-01)

Autoimmune Dry Eye without Significant Ocular Surface Co-Morbidities and Mental Health
by: Zahra Ashena, et al.
Published: (2020-10-01)

Autoimmunity, part B : novel applications of basic research /
by: International Conference on Autoimmunity (5th : 2006 : Sorrento, Italy), et al.
Published: (2007)

Interference of B lymphocyte tolerance by prolactin in rheumatic autoimmune diseases
by: Mohammad Javad Mousavi, et al.
Published: (2023-06-01)

Prevalence of fibromyalgia in patients with ankylosing spondylitis
by: Aref Hosseinian Amiri, et al.
Published: (2014-01-01)

Prevalence of autoimmune thyroiditis among children with autoimmune hepatitis
by: Engy Adel Mogahed, et al.
Published: (2024-04-01)

Cadherin Signaling in Cancer and Autoimmune Diseases
by: Margherita Sisto, et al.
Published: (2021-12-01)

Multimodality Evaluation of Aortic Insufficiency and Aortitis in Rheumatologic Diseases
by: Eunjung Choi, et al.
Published: (2022-04-01)

The Effectiveness and Retention Rate of Iguratimod in Japanese Rheumatoid Arthritis Patients with/without Methotrexate in Daily Medical Care
by: Asuka Inoue, et al.
Published: (2020-10-01)